ADIPOQ and Other metabolic disease: Lately, the study of adiponectin and BDNF focuses on the finding of common therapy between metabolic disorders and CNS disease and emphasizes a greater understanding of the common regulatory mechanisms both in metabolic syndromes and brain dysfunction [72].